You are here: Industry Insights > tuberculosis

News List

HitGen Launching Initiative to Discover New Medicines to Combat Tuberculosis and Malaria en-cphi.cn
August 03, 2018
Grant Funding provided by the Bill & Melinda Gates Foundation to Use HitGen’s DNA-Encoded Library Technology
A protein linking Parkinson's and tuberculosis could spur better drugs for both fiercebiotech
May 29, 2018
A team of scientists has discovered that an immune mechanism that clears bacterial infections may also play a role in causing Parkinson's disease.
Cancer drug helps treat tuberculosis by restoring leaky blood vessels europeanpharmaceuticalreview
May 02, 2018
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice…
Eisai forms partnership to find new tuberculosis treatment pharmafile
April 16, 2018
Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of Chicago, entering into a new research partnership to develop a new treatment for tuberculosis (TB).
Blood test found to predict onset of TB up to two years in advance europeanpharmaceuticalreview
April 09, 2018
A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB…
World TB Day 2018: US Food and Drug Administration Clears PrimeStore® MTM prnasia
March 26, 2018
As Governments around the world push to eliminate TB, PrimeStore® MTM serves as a crucial new tool to facilitate safe and accurate TB diagnosis and expedite detection of M. tuberculosis drug resistance gene mutations.
New research into old antibiotic unearths potential improved TB drug europeanpharmaceuticalreview
December 07, 2017
A study by the University of Warwick and the Francis Crick Institute has enabled a deeper understanding of the mechanism of action of antibiotic drug, D-cycloserine, which holds promise for future TB treatment.
Research finds gastric acid suppressant lansoprazole could target tuberculosis pharmaceutical-business
November 24, 2017
A new research in the UK suggests that a cheap and commonly used drug to treat heartburn, gastritis and ulcers has the potential to target Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB).
Urgent need for greater political commitment to end tuberculosis: WHO Global TB Report 2017 biospectrumasia
November 01, 2017
For the first time the Global TB Report presents results from a new multisectoral monitoring framework that identifies linkages with the TB epidemic across seven Sustainable Development Goals (SDGs)
TB Alliance declares potential of two novel TB drugs biospectrumasia
October 13, 2017
Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration.

Previous page 1 2 3 4 Next page